89369-3
Zika virus non-structural protein 1 IgM Ab [Units/volume] in Serum or Plasma by Immunoassay
Active
Part Description
LP221384-3 Zika virus non-structural protein 1
The Zika virus (ZIKV) nonstructural protein 1 (NS1) is secreted by infected cells and is involved in immune evasion and pathogenesis. While there is some structural similarity between ZIKV NS1 and NS1 from other flaviviruses, antibodies to ZIKV NS1 have been found to be relatively ZIKV-specific. [PMID: 27417494]
Zika virus (ZIKV) is a flavivirus transmitted primarily by the Aedes mosquito which was first identified in a sentinel monkey in the Zika forest in Uganda in 1947. Since 2014 it has spread explosively in the Americas where it has infected hundreds of thousands of people. About 80% of those infected are asymptomatic. Common symptoms include fever, headache, rash, arthralgia and conjunctivitis. Since the end of 2015, there has been an increase in ZIKV-associated cases of Guillain-Barre syndrome and a tremendous increase in cases of microcephaly in fetuses and newborns in Brazil, raising worldwide public health concern. Recent predictions are that the mosquito species A. Albopictus, which can hibernate and survive cool temperatures, will carry ZIKV to more temperate areas of North America, Australia and Southern Europe. It is still not clear whether ZIKV in humans increases viral titers enough to trigger a new cycle when an infected person is bitten by a naïve mosquito. Direct human-to-human transmission has been documented to occur perinatally, sexually (primarily through semen), through breastfeeding, blood transfusion and through occupational transmission in the laboratory setting. There are currently no specific anti-viral agents, vaccination or medical prophylaxis available. [PMID: 27148186]
ZIKV itself can be detected during the acute phase of infection (4-6 days) using PCR-based methods; alternatively, ZIKV-specific IgM antibodies or a significant titer increase of ZIKV-specific IgG is proof of acute infection. Antibody titers should be performed using serum samples from the acute and convalescent stages with at least 2 weeks between blood draws.
Source: Regenstrief LOINC, PMID: 27417494
Fully-Specified Name
- Component
- Zika virus non-structural protein 1 Ab.IgM
- Property
- ACnc
- Time
- Pt
- System
- Ser/Plas
- Scale
- Qn
- Method
- IA
Additional Names
- Short Name
- ZIKV NS1 IgM SerPl IA-aCnc
- Display Name
- ZIKV non-structural protein 1 IgM IA Qn
- Consumer Name Alpha
- Zika virus non-structural protein 1 IgM antibody, Blood
Basic Attributes
- Class
- MICRO
- Type
- Laboratory
- First Released
- Version 2.64
- Last Updated
- Version 2.65
- Change Reason
- Updated the System from Ser to Ser/Plas since this test can be performed on plasma specimens as well.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
89368-5 | Zika virus non-structural protein 1 IgM panel - Serum or Plasma by Immunoassay |
Member of these Groups
LOINC Group | Group Name |
---|---|
LG32774-8 | Zika virus |
Language Variants
Tag | Language | Translation |
---|---|---|
zh-CN | Chinese (China) | 寨卡病毒非结构蛋白 1 抗体.IgM: Synonyms: |
nl-NL | Dutch (Netherlands) | zikavirus niet-structureel proteïne 1 As.IgM: Synonyms: |
es-ES | Spanish (Spain) | Proteína no estructural del virus del Zica IgM: |
fr-FR | French (France) | Zika virus protéine non structurelle 1 Ac IgM: |
it-IT | Italian (Italy) | Zika virus, proteina non strutturale 1 Ab.IgM: Synonyms: |
de-DE | German (Germany) | Zika-Virus Nichtstrukturprotein 1 Ak.IgM: |
es-MX | Spanish (Mexico) | Proteína 1 Ab.IgM no estructural del virus del Zika: |
Example Units
Unit | Source |
---|---|
{EIA_index} | Example UCUM Units |
LOINC Terminology Service (API) using HL7® FHIR®
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=89369-3
LOINC Copyright
Copyright © 2023 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright